favipiravir

ALK receptor tyrosine kinase ; Homo sapiens







1 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35225067 Experiences of the combined use of Favipiravir in patients using Lorlatinib and Brigatinib. 2022 Feb 28 3